ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Outcome measures"

  • Abstract Number: 2732 • 2016 ACR/ARHP Annual Meeting

    Meaningful Involvement of Patients in the Development of a Core Outcome Set for Psoriatic Arthritis

    Maarten de Wit1, Alexis Ogdie2, Willemina Campbell3, Philip J Mease4, Niti Goel5, Laure Gossec6, Ying Ying Leung7, Christine Lindsay8, Penelope Palominos Jr.9, Ingrid Steinkoenig10, Suzanne Grieb11 and Ana-Maria Orbai12, 1Medical Humanities, VU Medical Centre, Amsterdam, Netherlands, 2University of Pennsylvania, Philadelphia, PA, 3Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, 4Rheumatology Research, Swedish Medical Center, Seattle, WA, 5Quintiles; Duke University School of Medicine, Durham, NC, 6Paris 06 University and AP-HP, Hôpital Pitié Salpêtrière, Paris, France, 7North District Hospital, Hong Kong, China, 8Medical Affairs, Amgen Inc, Thousand Oaks, CA, 9Rheumatology, Hospital de Clinicas de Porto Alegre, Santa Cecilia, Brazil, 10Patient Research Partner, Cleveland, OH, 11Psychology, Johns Hopkins University, Baltimore, MD, 12Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: The Group for Research of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) working group recently obtained endorsement at the…
  • Abstract Number: 2741 • 2016 ACR/ARHP Annual Meeting

    Reliability and Construct Validity of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire – Independent Validation Study in a UK Cohort

    Richard Holland1, William Tillett1,2, Eleanor Korendowych1, Charlotte Cavill1,3, Mel Brooke4 and Neil J McHugh5, 1Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 2Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom, 3Rheumatology, Bath Institute for Rheumatic Disease, Bath, United Kingdom, 4PsAZZ Support Group, Bath, United Kingdom, 5Royal National Hospital for Rheumatic Diseases and Dept Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom

    Background/Purpose: Patient reported outcomes (PROs) have been found to be reliable indicators of baseline status, change during treatment, and are predictive of long-term outcome. A…
  • Abstract Number: 2754 • 2016 ACR/ARHP Annual Meeting

    Self-Reported Physical Activity Questionnaire in Axial Spondyloarthritis: Modification of the Squash

    Fiona Maas1, Anna Jetske Baron1,2, Freke Wink3, Reinhard Bos3, Yvo Kamsma2, Hendrika Bootsma4, Suzanne Arends1,3 and Anneke Spoorenberg1,3, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Center for Human Movement Sciences, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Rheumatology, Medical Center Leeuwarden, Leeuwarden, Netherlands, 4Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands

    Background/Purpose:  Improvement of physical function and physical activity are important goals in the management of axial spondyloarthritis (axSpA). Although physical function is included in the…
  • Abstract Number: 2921 • 2016 ACR/ARHP Annual Meeting

    Patient Participation in Patient Reported Outcome Instrument Development in Systemic Sclerosis

    John Pauling1,2, Tracy M. Frech3,4, Robyn T. Domsic5 and Marie Hudson6,7, 1Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom, 2Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 3Internal Medicine, Salt Lake City VAMC, Salt Lake, UT, 4Internal Medicine-Division of Rheumatology, University of Utah School of Medicine, SLC, UT, 5Medicine - Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, 6Medicine, McGill University, Montreal, QC, Canada, 7Medicine/Rheumatology, Jewish General Hospital, Lady Davis Research Institute, Montreal, QC, Canada

    Background/Purpose:  The patient perspective captured using Patient-Reported Outcome (PRO) instruments provide valuable insight into the patient condition not always captured by physician-derived assessment tools. Target…
  • Abstract Number: 2963 • 2016 ACR/ARHP Annual Meeting

    BehçEt’s Disease in Children: Eastern Mediterranean Experience

    Hafize Emine Sonmez1, Ezgi Deniz Batu1, Betul Sozeri2, Yonatan Butbul Aviel3, Yelda Bilginer4 and Seza Ozen5, 1Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 2Pediatric Rheumatology, Erciyes University Faculty of Medicine, Kayseri, Turkey, 3Pediatric Rheumatology, Rambam Medical Center, Haifa, Israel, 4Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, ANKARA, Turkey, 5Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey

    Background/Purpose: Behçet’s disease (BD) is a variable vessel vasculitis which is more common in adults. The most widely used diagnostic criteria for adult onset disease…
  • Abstract Number: 3016 • 2016 ACR/ARHP Annual Meeting

    Validity of a 2-Component Disease Activity Score for Accurate Assessment of Synovitis in Rheumatoid Arthritis

    Elizabeth M.A. Hensor1,2, Paul McKeigue3, Philip G. Conaghan1,2, Maya H. Buch1,2, Jennifer H. Barrett2,4, Jackie L. Nam1,2, Marco Colombo5, Athina Spiliopoulou5,6, Felix Agakov6, Stephen Kelly7, Myles J. Lewis7, Costantino Pitzalis7, Paul Emery1,2, Ann W. Morgan1,2 and IACON Consortium & PEAC Consortium, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, 3Medical School, Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United Kingdom, 4School of Medicine, University of Leeds, Leeds, United Kingdom, 5Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United Kingdom, 6Pharmatics Limited, Edinburgh, Edinburgh, United Kingdom, 7Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

    Background/Purpose: The original Disease Activity Score (DAS) was derived from clinicians’ therapeutic decisions1, which may have been influenced by patient-subjective factors such as general health…
  • Abstract Number: 527 • 2016 ACR/ARHP Annual Meeting

    The Summed Bilateral Elbow Extension Angle in Rheumatoid Arthritis Correlates with the DAS28-CRP(4) and May be an Independent Marker of Bad Prognosis

    John P. Case1, Congbin Wang2 and Heidi Tucker3, 1Internal Medicine/Rheumatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 2Internal medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 3Rush Medical College, Chicago, IL

    Background/Purpose: The elbow is an easily-examined joint and an important determinant of morbidity in rheumatoid arthritis (RA).  In active RA the measured elbow extension angle,…
  • Abstract Number: 3095 • 2016 ACR/ARHP Annual Meeting

    What Should be the Primary Target of ‘Treat to Target’ in Psa?

    Laura C. Coates1,2, Paul Emery3, Philip G. Conaghan1 and Philip S. Helliwell1, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, 3NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

    Background/Purpose:  In 2013, Treat to Target (T2T) in SpA Recommendations by expert consensus stated that the target of treatment should be remission or inactive disease.…
  • Abstract Number: 553 • 2016 ACR/ARHP Annual Meeting

    Validation of Index of Activity Speed (Timed Up and Go test) for Outcome Measure of Patients with Long-Standing Rheumatoid Arthritis: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function

    Toshihisa Kojima1, Hajime Ishikawa2,3, Sakae Tanaka4, Nobuhiko Haga5, Keiichiro Nishida6, Masao Yukioka7, Jun Hashimoto8, Hisaaki Miyahara9, Yasuo Niki10, Tomoatsu Kimura11, Hiromi Oda12, Shuji Asai13, Koji Funahashi1, Masayo Kojima14 and Naoki Ishiguro15, 1Department of Orthopedic Surgery, Nagoya University Hospital, Nagoya, Japan, 2Orthopedic Surgery, Niigata Rheumatic Center, Shibata, Japan, 3Orthopedic Surgery, Niigata Rheumatic Center, Shinata, Japan, 4Department of Orthopaedic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 5Rehabilitation Medicine, The University of Tokyo Hospital, Tokyo, Japan, 6Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama city, Japan, 7Orthopedic Surgery, Yukioka Hospital, Osaka, Japan, 8Dept of Rheumatology, Osaka-Minami Medical Center, Kawachinagano City, Japan, 9Department of Rheumatology and Orthopaedic Surgery, Kyushu Medical Center, Fukuoka, Japan, 10Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan, 11Department of rthopaedic Surgery, Faculty of Medicine, University of Toyama, Toyama, Japan, 12Orthopedic Surgery, Saitama Medical Univeristy, Morohongo Moroyama, Japan, 13Nagoya University Hospital, Nagoya, Japan, 14Medical education, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan, 15Department of Orthopedic Surgery, Nagoya University, Graduate School & Faculty of Medicine, Nagoya, Japan

    Background/Purpose: Total management including reconstructive joint surgery and rehabilitation should be needed for further improvements of physical function for long-standing RA patients. It is very…
  • Abstract Number: 3115 • 2016 ACR/ARHP Annual Meeting

    Reconsidering the Juvenile Idiopathic Arthritis Core Set: How Patients and Caregivers Define Disease Activity

    Jennifer R. Horonjeff1, Susan Thornhill2, Daniel B. Horton3, Jennifer N. Stinson4, Anjali Fortna5, Stephanie Luca6, Arlene Vinci7, Laura C. Marrow8, Emily L. Creek7, Meredith Riebschleger9, Alessandro Consolaro10, Jane Munro11, Vibeke Strand12, Clifton Bingham III13 and Esi Morgan14, 1Rheumatology, Columbia University Medical Center, New York, NY, 2Thornhill Associates, Hermosa Beach, CA, 3Pediatrics, Division of Pediatric Rheumatology, Rutgers Robert Wood Johnson Medical School, Rutgers Biomedical and Health Sciences, New Brunswick, NJ, 4Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada, 5Columbia University Medical Center, New York, NY, 6The Hospital for Sick Children, Toronto, ON, Canada, 7Consumer Health, Arthritis Foundation, Atlanta, GA, 8Arthritis Foundation, Atlanta, GA, 9Pediatric Rheumatology & Health Services Research, University of Michigan, Ann Arbor, MI, 10Pediatria II - Reumatologia, PRINTO, Istituto Giannina Gaslini, Genoa, Italy, 11Rheumatology, Royal Children's Hospital, Parkville, Australia, 12Stanford University School of Medicine, Palo Alto, CA, 13Divisions of Rheumatology and Allergy, Department of Medicine, Johns Hopkins University, Johns Hopkins University, Baltimore, MD, 14Pediatric Rheumatology, Cincinnati Children's Hospital, Cincinnati, OH

    Background/Purpose: The current JIA Core Set (ACR Pediatric 30) contains items that should be assessed in clinical trials for children with JIA. It was developed…
  • Abstract Number: 554 • 2016 ACR/ARHP Annual Meeting

    Characteristics of Functional Impairment in Patients with Long-Standing Rheumatoid Arthritis Based on Range of Motion of Joints: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function

    Toshihisa Kojima1, Hajime Ishikawa2, Sakae Tanaka3, Nobuhiko Haga4, Keiichiro Nishida5, Masao Yukioka6, Jun Hashimoto7, Hisaaki Miyahara8, Yasuo Niki9, Hiromi Oda10, Shuji Asai11, Koji Funahashi1, Masayo Kojima12 and Naoki Ishiguro13, 1Department of Orthopedic Surgery, Nagoya University Hospital, Nagoya, Japan, 2Orthopedic Surgery, Niigata Rheumatic Center, Shibata, Japan, 3Department of Orthopaedic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 4Rehabilitation Medicine, The University of Tokyo Hospital, Tokyo, Japan, 5Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama city, Japan, 6Orthopedic Surgery, Yukioka Hospital, Osaka, Japan, 7Dept of Rheumatology, Osaka-Minami Medical Center, Kawachinagano City, Japan, 8Department of Rheumatology and Orthopaedic Surgery, Kyushu Medical Center, Fukuoka, Japan, 9Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan, 10Orthopedic Surgery, Faculty of Medicine, Saitama Medical Univeristy, Morohongo Moroyama, Japan, 11Nagoya University Hospital, Nagoya, Japan, 12Medical education, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan, 13Department of Orthopedic Surgery, Nagoya University, Graduate School & Faculty of Medicine, Nagoya, Japan

    Background/Purpose: Even now, in clinical practice, most of RA patients have long-standing disease and structural damage in their joints. Reconstructive joint surgery should be needed…
  • Abstract Number: 3179 • 2016 ACR/ARHP Annual Meeting

    Scale Structure and Measurement Properties of a Disease Specific Patient-Reported Outcome for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

    Joanna C. Robson1,2,3, Jill Dawson4, Judy A. Shea5, Helen Doll6, Susan Ashdown7, Renee Borchin8, Ebony Easley9, John T. Farrar10, Don Gebhart11, Katherine Kellom12, Georgia Lanier13, Raashid Luqmani14, Carol A McAlear15, John Mills16, Nataliya Milman17,18,19, Jacqueline Peck7, Gunnar Tomasson20, Peter F. Cronholm9 and Peter A. Merkel21, 1Faculty of Health and Applied Science, University of the West of England, Bristol, United Kingdom, 2Department of Rheumatology, University Hospitals Bristol NHS Trust, Bristol, United Kingdom, 3School of Clinical Sciences, University of Bristol, Bristol, United Kingdom, 4Nuffield Department of Population Health HSRU, University of Oxford, Oxford, United Kingdom, 5Division of General Internal Medicine, University of Pennsylvania, Philadelphia, PA, 6Department of Population Health, University of East Anglia, Norwich, United Kingdom, 7Oxford, Oxford, United Kingdom, 8University of South Florida, Tampa, FL, 9Department of Family Medicine and Community Health, The University of Pennsylvania, Philadelphia, PA, 10University of Pennsylvania, Philadelphia, PA, 11Columbus, Columbus, OH, 12PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, United Kingdom, 13NONE, Framingham, MA, 14NDORMS , Rheumathology, Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United Kingdom, 15Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 16Vasculitis UK, Sheffield, United Kingdom, 17Department of Medicine, University of Ottawa, Ottawa, ON, Canada, 18The Ottawa Hospital, Ottawa, ON, Canada, 19Department of Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON, Canada, 20Dept of Public Health Sciences, University of Iceland, Reykjavik, IS, 21Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

    Background/Purpose:  Candidate questionnaire items were produced following in-depth qualitative research in the UK, US, and Canada plus cognitive interviews, extensive piloting and independent linguistic and…
  • Abstract Number: 592 • 2016 ACR/ARHP Annual Meeting

    Impact of Adherence to Tumor Necrosis Factor Inhibitors on Radiographic Outcomes in US Veterans with Rheumatoid Arthritis

    Grant W. Cannon1, Alan R. Erickson2, Chia-Chen Teng3, Tina Huynh3, Sharon Austin4, Bradley S. Stolshek5, Alex Mutebi6, David Collier5, Sally W. Wade7 and Brian Sauer3, 1Division of Rheumatology, Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 2Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 3Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 4VAMC, Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 5Amgen, Thousand Oaks, CA, 6Global Health Economics, Amgen, Thousand Oaks, CA, 7Wade Outcomes Research and Consulting, Salt Lake City, UT

    Background/Purpose:   Tumor necrosis factor inhibitors (TNFi) are effective therapy for rheumatoid arthritis (RA) and have been shown to reduce progression of joint structural damage…
  • Abstract Number: 854 • 2016 ACR/ARHP Annual Meeting

    The Ducas: Proposal for a Digital Ulcer Assessment Score in Scleroderma

    Cosimo Bruni1, Tanaka Ngcozana2, Francesca Braschi3, Guya Piemonte4, Laura Benelli4, Serena Guiducci5, Silvia Bellando-Randone3, Jonathan Grotts6, Christopher Denton7, Daniel E. Furst8 and Marco Matucci-Cerinic5, 1Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Firenze, Italy, 2Rheumatology Department, Lower, Royal Free hospital, London, United Kingdom, 3Department of Clinical and Experimental Medicine, Division of Rheumatology, University of Florence, Firenze, Italy, 4University of Florence, Florence, Italy, 5Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy, 6Biostatistics, University of California Los Angeles, Los Angeles, CA, 7Division of Medicine, Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom, 8Division of Rheumatology, Department of Internal Medicine, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose: No objective measure is presently available to assess digital ulcer (DU) in SSc patients apart from “healed/non healed” and experience-based clinical judgment. The aim…
  • Abstract Number: 1281 • 2016 ACR/ARHP Annual Meeting

    Feasibility and Reliability of the Spondyloarthritis Research Consortium of Canada Sacroiliac Joint Inflammation Score for Children with Spondyloarthritis

    Nancy A. Chauvin1, Walter P. Maksymowych2,3, Robert G. Lambert4, Jacob Jaremko5, David M. Biko1, Timothy G. Brandon6, Joel Paschke2 and Pamela F. Weiss7,8, 1Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, 2CaRE Arthritis, Edmonton, AB, Canada, 3Medicine, University of Alberta, Edmonton, AB, Canada, 4Radiology, University of Alberta, Edmonton, AB, Canada, 5Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, 6Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, 7Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 8Division of Rheumatology, Center for Pediatric Clincial Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: We lack a method to quantify severity of inflammation in the pediatric sacroiliac joint. We evaluated the reliability and construct validity of the Spondyloarthritis…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 49
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology